Table 2 Serial CMR outcomes: Recovery of global functional outcomes in the total CMR population
Total CMR population | CTO PCI (n = 80) | No-CTO PCI (n = 100) | P-value |
|---|---|---|---|
Left ventricular ejection fraction (%) | |||
Baseline | 40.6 (11.8) | 41.7 (12.1) | 0.55 |
4 months FU | 45.3 (11.6) | 45.5 (11.8) | 0.87 |
Δ LVEF | 4.6 (8.3) | 3.8 (8.1) | 0.52 |
Left ventricular end-diastolic volume (ml) | |||
Baseline | 210.1 (53.4) | 209.5 (55.1) | 0.95 |
4 months FU | 215.6 (54.6) | 212.5 (53.9) | 0.71 |
Δ LVEDV | 5.5 (32.4) | 3.0 (25.7) | 0.57 |
Infarct size (g) a | |||
Baseline | 11.7 (10.5) | 11.9(11.1) | 0.94 |
4 months FU | 7.5 (6.4) | 7.1 (5.4) | 0.70 |
Δ Infarct size | −4.3 (8.0) | −4.8 (8.6) | 0.72 |